• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Organ Preservation Solutions Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 Product Image

Organ Preservation Solutions Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

  • Published: February 2014
  • Region: Global
  • 80 Pages
  • Transparency Market Research

FEATURED COMPANIES

  • 21st Century Medicine
  • BioLife Solutions, Inc.
  • BioTime, Inc.
  • Bristol-Myers Squibb
  • CryoLife, Inc.
  • Lifeline Scientific
  • MORE

'Organ Preservation Solutions Market (By Solutions - Viaspan, Custodiol HTK, Renograf, Hypothermosol, Perfadex, Lifor, HBS Solution, siRNA Transplant Solution and Others, and By Preservation Techniques- Hypothermic Perfusion Preservation, Static Cold Storage and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019'

This report studies the global organ preservation solutions market based on the various solutions available in the market in which organs are preserved, type of preservation techniques used and the major geographic markets. The global market for organ preservation solutions has been segmented into nine major solutions that include Viaspan, Custodiol HTK, Renograf, Hypothermosol, Perfadex, Lifor, HBS Solution, siRNA Transplant Solution and others (Ross-Marshall Citrate Solutions, Celsior Solution, Phosphate-Buffered Sucrose Solution, ET-Kyoto, TranSend, HetaFreeze, MaPersol and CryoStor).

On the basis of preservation techniques, the market has been segmented into three categories namely hypothermic perfusion preservation (HPP), static cold storage (SCS) and others (that include normothermic preservation and oxygen insufflation READ MORE >

Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology

Chapter 2 Executive Summary

Chapter 3 Market Overview
3.1 Introduction
3.2 Market Drivers
3.2.1 Aging global population
3.2.1.1 Global rate of aging population
3.2.2 Technological advancements
3.2.3 Increasing reimbursement scenario
3.2.4 Increase in per capita healthcare expenditure
3.3 Market Restraints
3.3.1 Lack of organ donors
3.3.1.1 Widening Gap Between Patients Receiving Organ Transplants and Number of Donors in the U.S. (1998 - 2010)
3.3.2 High cost of procedure
3.4 Market Opportunities
3.4.1 Collaboration with research-oriented organizations and medical institutes to ensure retention of customer base
3.5 Porter’s Five Force Analysis for the Global Organ Preservation Solutions Market
3.5.1 Bargaining power of suppliers
3.5.2 Bargaining power of buyers
3.5.3 Threat of substitutes
3.5.4 Threat of new entrants
3.5.5 Competitive rivalry
3.6 Market Attractiveness Analysis: Global Organ Preservation Solutions Market, by Geography

Chapter 4 Global Organ Preservation Solutions Market, By Solution, 2011 – 2019 (USD Million)
4.1 Overview
4.1.1 Global Organ Preservation Solutions Market Revenue, by Solution Type, 2011 - 2019 (USD Million)
4.1.2 Comparative Analysis: Global Organ Preservation Solutions Market, by Solution Type, 2012 & 2019 (Value %)
4.2 Viaspan
4.2.1 Global Viaspan Market Revenue, 2011 - 2019 (USD Million)
4.3 Custodiol HTK – (Histidine-Tryptophan-Ketoglutarate) Solution
4.3.1 Global Custodiol Market Revenue, 2011 - 2019 (USD Million)
4.4 Renograf
4.4.1 Global Renograf Market Revenue, 2011 - 2019 (USD Million)
4.5 Hypothermosol
4.5.1 Global Hypothermosol Market Revenue, 2011 - 2019 (USD Million)
4.6 Perfadex
4.6.1 Global Perfadex Market Revenue, 2011 - 2019 (USD Million)
4.7 Lifor
4.7.1 Global Lifor Market Revenue, 2011 - 2019 (USD Million)
4.8 Human bioSystem (HBS) Solution
4.8.1 Global HBS Solution Market Revenue, 2011 - 2019 (USD Million)
4.9 siRNA Transplant Solution
4.9.1 Global siRNA Transplant Solution Market Revenue, 2011 - 2019 (USD Million)
4.10 Others
4.10.1 Global Other Solutions Market Revenue, 2011 - 2019 (USD Million)

Chapter 5 Global Organ Preservation Solutions Market, By Preservation Technique, 2011 – 2019 (USD Million)
5.1 Overview
5.1.1 Global Organ Preservation Solutions Market Revenue, by Preservation Technique, 2011 - 2019 (USD Million)
5.1.2 Comparative Analysis: Global Organ Preservation Solutions Market, by Preservation Technique, 2012 & 2019 (Value %)
5.2 Hypothermic Perfusion Preservation (HPP)
5.2.1 Global Hypothermic Perfusion Preservation Market Revenue, 2011 - 2019 (USD Million)
5.3 Static Cold Storage (SCS)
5.3.1 Global Static Cold Storage Market Revenue, 2011 - 2019 (USD Million)
5.4 Others
5.4.1 Global Other Preservation Techniques Market Revenue, 2011 - 2019 (USD Million)

Chapter 6 Global Organ Preservation Solutions Market, By Geography, 2011 – 2019 (USD Million)
6.1 Overview
6.1.1 Global Organ Preservation Solutions Market Revenue, by Geography, 2011 - 2019 (USD Million)
6.1.2 Comparative Analysis: Global Organ Preservation Solutions Market, by Geography, 2012 & 2019 (Value %)
6.2 North America
6.2.1 North America Organ Preservation Solutions Market Revenue, 2011 - 2019 (USD Million)
6.3 Europe
6.3.1 Europe Deceased Donation Rate (Per Million of Population), by Country, 2011
6.3.2 Europe Organ Donation and Transplantation Data, 2011
6.3.3 Donation and Transplantation Number Per European Country, 2011
6.3.4 Europe Organ Preservation Solutions Market Revenue, 2011 - 2019 (USD Million)
6.4 Asia Pacific
6.4.1 Organ Donation and Transplantation Data for Japan (2009 - 2013)
6.4.2 Asia Pacific Organ Preservation Solutions Market Revenue, 2011 - 2019 (USD Million)
6.5 Rest of the World (RoW)
6.5.1 RoW Organ Preservation Solutions Market Revenue, 2011 - 2019 (USD Million)

Chapter 7 Competitive Landscape
7.1 Market Share by Key Players, 2012 (%)

Chapter 8 Recommendations
8.1 Long term contracts with healthcare service providers
8.2 Broadening of distribution network
8.3 Product innovation

Chapter 9 Company Profiles
9.1 21st Century Medicine
9.1.1 Company Overview
9.1.2 Product Portfolio
9.2 BioLife Solutions, Inc.
9.2.1 Company Overview
9.2.2 Financial Overview
9.2.3 Product Portfolio
9.2.4 Business Strategies
9.2.5 Recent Developments
9.3 BioTime, Inc.
9.3.1 Company Overview
9.3.2 Financial Overview
9.3.3 Product Portfolio
9.3.4 Business Strategies
9.3.5 Recent Developments
9.4 Bristol-Myers Squibb
9.4.1 Company Overview
9.4.2 Financial Overview
9.4.3 Product Portfolio
9.4.4 Business Strategies
9.4.5 Recent Developments
9.5 Claris Lifesciences Limited
9.5.1 Company Overview
9.5.2 Financial Overview
9.5.3 Product Portfolio
9.5.4 Business Strategies
9.5.5 Recent Developments
9.6 CryoLife, Inc.
9.6.1 Company Overview
9.6.2 Financial Overview
9.6.3 Product Portfolio
9.6.4 Business Strategies
9.6.5 Recent Developments
9.7 Dr. Franz Köhler Chemie GmbH
9.7.1 Company Overview
9.7.2 Product Portfolio
9.7.3 Business Strategies
9.8 Lifeline Scientific
9.8.1 Company Profile
9.8.2 Financial Overview
9.8.3 Product Portfolio
9.8.4 Business Strategies
9.8.5 Recent Developments
9.9 Teva Pharmaceutical Industries Ltd.
9.9.1 Company Profile
9.9.2 Financial Overview
9.9.3 Product Portfolio
9.9.4 Business Strategies
9.9.5 Recent Developments
9.10 ToleroTech, Inc.
9.10.1 Company Profile
9.10.2 Product Portfolio
9.10.3 Business Strategies
9.11 XVIVO Perfusion AB
9.11.1 Company Overview
9.11.2 Financial Overview
9.11.3 Product Portfolio
9.11.4 Business Strategies

List of Figures

FIG. 1 Organ Preservation Solutions Market Segmentation
FIG. 2 Global Organ Preservation Solutions Market, by Solution, 2012 (USD Million)
FIG. 3 Global Organ Preservation Solutions Market, by Preservation Technique, 2012 (USD Million)
FIG. 4 Global Rate of Aging Population
FIG. 5 Gap Between Organ Transplant and Donors in the U.S. (1998 - 2010)
FIG. 6 Porter’s Five Force Analysis: Global Organ Preservation Solutions Market
FIG. 7 Market Attractiveness Analysis: Global Organ Preservation Solutions Market, by Geography
FIG. 8 Comparative Analysis: Global Organ Preservation Solutions Market, by Solution Type, 2012 & 2019 (Value %)
FIG. 9 Global Viaspan Market Revenue, 2011 – 2019 (USD Million)
FIG. 10 Global Custodiol Market Revenue, 2011 – 2019 (USD Million)
FIG. 11 Global Renograf Market Revenue, 2011 – 2019 (USD Million)
FIG. 12 Global Hypothermosol Market Revenue, 2011 – 2019 (USD Million)
FIG. 13 Global Perfadex Market Revenue, 2011 – 2019 (USD Million)
FIG. 14 Global Lifor Market Revenue, 2011 – 2019 (USD Million)
FIG. 15 Global HBS Solution Market Revenue, 2011 – 2019 (USD Million)
FIG. 16 Global siRNA Transplant Solution Market Revenue, 2011 – 2019 (USD Million)
FIG. 17 Global Other Solutions Market Revenue, 2011 – 2019 (USD Million)
FIG. 18 Comparative Analysis: Global Organ Preservation Solution Market, by Preservation Technique, 2012 & 2019 (Value %)
FIG. 19 Global Hypothermic Perfusion Preservation Market Revenue, 2011 – 2019 (USD Million)
FIG. 20 Global Static Cold Storage Market Revenue, 2011 – 2019 (USD Million)
FIG. 21 Global Other Preservation Techniques Market Revenue, 2011 – 2019 (USD Million)
FIG. 22 Comparative Analysis: Global Organ Preservation Solution Market, by Geography, 2012 & 2019 (Value %)
FIG. 23 North America Organ Preservation Solutions Market Revenue, 2011 – 2019 (USD Million)
FIG. 24 Europe Organ Preservation Solutions Market Revenue, 2011 – 2019 (USD Million)
FIG. 25 Asia Pacific Organ Preservation Solutions Market Revenue, 2011 – 2019 (USD Million)
FIG. 26 RoW Organ Preservation Solutions Market Revenue, 2011 – 2019 (USD Million)
FIG. 27 Market Share by Key Players, 2012 (%)
FIG. 28 Annual Revenue: BioLife Solutions, Inc., 2010 – 2012 (USD Million)
FIG. 29 Annual Revenue: BioTime Inc., 2010 – 2012 (USD Million)
FIG. 30 Annual Revenue: Bristol-Myers Squibb, 2010 – 2012 (USD Million)
FIG. 31 Annual Sales: Claris Lifesciences Ltd., 2010 – 2012 (USD Million)
FIG. 32 Annual Revenue: CryoLife, Inc., 2010 – 2012 (USD Million)
FIG. 33 Annual Revenue: Lifeline Scientific, 2010 – 2012 (USD Million)
FIG. 34 Annual Revenue: Teva Pharmaceutical Industries Ltd., 2010 – 2012 (USD Million)
FIG. 35 Annual Sales: XVIVO Perfusion AB, 2010 – 2012 (USD Million)

List of Tables

TABLE 1 Market Snapshot: Global Organ Preservation Solutions Market
TABLE 2 Global Organ Preservation Solutions Market Revenue, by Solution, 2011 – 2019 (USD Million)
TABLE 3 Global Organ Preservation Solutions Market Revenue, by Preservation Technique, 2011 – 2019 (USD Million)
TABLE 4 Global Organ Preservation Solutions Market Revenue, by Geography, 2011 – 2019 (USD Million)
TABLE 5 Organ Donation and Transplantation Data for Japan (2009 - 2013)

The rise in incidences of organ failure in kidney, liver and heart patients across the globe is augmenting the demand for organ transplant procedures.This has further led to a rise in the demand for organ preservation solutions that help maintain the organs’ viability from the time of donation to transplantation. Market growth for organ preservation solutions will also be propelled by the rise in the number of elderly people worldwide since, risk of organ failure in people of this age group is higher. Also, the American Society of Nephrology states that an aged patient’s body shows less graft rejection and that has led to increased preference for organ transplants by surgeons for them. According to the U.S. Department of Health and Human Services, in 2011, 60% of the total number of individuals who underwent organ transplantation procedures in the U.S. were beyond 50 years of age. The global market for organ preservation solutions is expected to grow at a CAGR of 16.5% from 2013 to 2019 to reach an estimated value of USD 0.20 billion in 2019.

The growth of this market will also be driven by the launch of technologically advanced products such as Lifor. Lifor is manufactured by Lifeblood Medical, Inc. and is currently utilized for research purposes only. It is also termed as a blood surrogate and once its effectiveness is clinically proven for preserving human and veterinary organs, the market for the same will grow significantly. Both the developed and developing countries have recorded growth in per capita healthcare expenditure which would provide people with less expensive and better healthcare services. This will also enable the patients to afford organ transplant procedures and hence the organ preservation solutions market will grow. However, growth of this market may get hampered due to high cost of transplantation procedures and lack of organ donors which may shift the preferences of surgeons towards artificial organs.

The market for Custodiol, accounted for the largest share in terms of revenue of total organ preservation solutions market in 2012 and during the forecast period, is expected to grow at the highest CAGR. This growth will be due to the fact that it can be utilized to preserve various organs such as kidney, lungs, liver and pancreas. Also, it is a vintage preservation solution and hence has gained considerable popularity in the industry which has resulted in increasing preference for Custodiol over other solutions in the market. For instance, Custodiol is utilized extensively for preserving kidneys according to the U.S. National Institute of Health (NIH) journal.

Various type of techniques are used for preserving organs such as hypothermic perfusion preservation (HPP) and static cold storage (SCS). Currently, SCS is the most extensively utilized technique for preservation since it is cheaper than HPP and is more user friendly for physicians. However, with the increasing demand for organs and less number of organ donors, the HPP market is expected to foresee the highest growth since it is capable of preserving organs for longer duration of time with higher accuracy.

Geographically, the European market accounted for the largest share in terms of revenue in 2012 and is expected to grow at the highest CAGR during the forecast period. Various countries of the region like Spain follow opt out policy where a person, if has not opted for denial of organ donation, will be considered as an organ donor after death (brain death) automatically. This increases the number of donors in the region and hence will drive the growth of the market. The total number of deceased donors in the European region amounted to 9,604 in 2011 which was 9,152 in 2009.

The major players operating in the global organ preservation solutions market include Dr. Franz Köhler Chemie GmbH, Bristol-Myers Squibb, XVIVO Perfusion AB, Teva Pharmaceutical Industries Ltd., BioLife Solutions, Inc. and ToleroTech, Inc. These companies strive to maintain their leading position in the market by adopting various business strategies such as launch of innovative products and acquiring various competitors. For instance, Teva Pharmaceutical Industries Ltd. when acquired Barr Pharmaceuticals Ltd., added the leading product Custodiol in its product portfolio.

- 21st Century Medicine
- BioLife Solutions, Inc.
- BioTime, Inc.
- Bristol-Myers Squibb
- Claris Lifesciences Limited
- CryoLife, Inc.
- Dr. Franz Köhler Chemie GmbH
- Lifeline Scientific
- Teva Pharmaceutical Industries Ltd.
- ToleroTech, Inc.
- XVIVO Perfusion AB

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos